MAZE THERAPEUTICS INC
MAZE · NASDAQ
Updated at 2026-10-14 08:42:09
- Today's High
- $28.24
- Today’s Low
- $26.57
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $27.11
- Previous Close
- $27.70
- Volume
- 1.43M
- Market Cap
- $1.53B
- P/E Ratio
- --
- EPS
- $-2.51
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 171 OYSTER POINT BLVD, SOUTH SAN FRANCISCO, CA, UNITED STATES, 94080
- Country
- US
- Listing Date
- 2025-01-31
- Fiscal Year End
- December
- Shares Outstanding
- 55.35M
- CIK
- --
- Website
- www.mazetx.com
Maze Therapeutics, Inc., a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of renal, cardiovascular, related metabolic diseases, and obesity in the United States. The company is headquartered in South San Francisco, California.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$20M
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$48.03M
2026-03-31
$46.1M
2025-12-31
$37.56M
2025-09-30
$32.96M
Net Income
2026-06-30
-$44.72M
2026-03-31
-$24.2M
2025-12-31
-$34.56M
2025-09-30
-$30.08M
Net Profit Margin
2026-06-30
--
2026-03-31
-121.04%
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.76
2026-03-31
$-0.44
2025-12-31
$-0.65
2025-09-30
$-0.66
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$43.4M
2026-03-31
-$22.89M
2025-12-31
-$34.06M
2025-09-30
-$29.51M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $20M | $0 | $0 |
| Operating Expenses | $48.03M | $46.1M | $37.56M | $32.96M |
| Net Income | -$44.72M | -$24.2M | -$34.56M | -$30.08M |
| Net Profit Margin | -- | -121.04% | -- | -- |
| Earnings Per Share | $-0.76 | $-0.44 | $-0.65 | $-0.66 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$43.4M | -$22.89M | -$34.06M | -$29.51M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.